Your browser doesn't support javascript.
loading
Breast, Cervical, and Colorectal Cancer Screening: Patterns Among Women With Medicaid and Commercial Insurance.
Bonafede, Machaon M; Miller, Jeffrey D; Pohlman, Scott K; Troeger, Kathleen A; Sprague, Brian L; Herschorn, Sally D; Winer, Isabelle H.
Afiliação
  • Bonafede MM; Outcomes Research, IBM Watson Health, Cambridge, Massachusetts. Electronic address: mbonafed@us.ibm.com.
  • Miller JD; Outcomes Research, IBM Watson Health, Cambridge, Massachusetts.
  • Pohlman SK; Outcomes Research, Hologic, Inc., Marlborough, Massachusetts.
  • Troeger KA; Outcomes Research, Hologic, Inc., Marlborough, Massachusetts.
  • Sprague BL; Department of Surgery, University of Vermont Cancer Center, University of Vermont, Burlington, Vermont; Department of Radiology, University of Vermont Cancer Center, University of Vermont, Burlington, Vermont.
  • Herschorn SD; Department of Radiology, University of Vermont Cancer Center, University of Vermont, Burlington, Vermont.
  • Winer IH; Outcomes Research, IBM Watson Health, Cambridge, Massachusetts.
Am J Prev Med ; 57(3): 394-402, 2019 09.
Article em En | MEDLINE | ID: mdl-31377088
INTRODUCTION: Despite healthcare reforms mandating expanded insurance coverage and reduced out-of-pocket costs for preventive care, cancer screening rates remain relatively static. No study has measured cancer screening rates for multiple tests among non-Medicare patients. METHODS: This retrospective, population-based claims analysis, conducted in 2016-2017, of commercially insured and Medicaid-insured women aged 30-59 years enrolled in IBM MarketScan Commercial and Medicaid Databases (containing approximately 90 and 17 million enrollees, respectively) during 2010-2015 describes screening rates for breast, cervical, and colorectal cancer. Key outcomes were (1) proportion screened for breast, cervical, and colorectal cancer among the age-eligible population compared with accepted age-based recommendations and (2) proportion with longer-than-recommended intervals between tests. RESULTS: One half (54.7%) of commercially insured women aged 40-59 years (n=1,538,444) were screened three or more times during the 6-year study period for breast cancer; for Medicaid-insured women (n=78,897), the rates were lower (23.7%). One third (43.4%) of commercially insured and two thirds (68.9%) of Medicaid-insured women had a >2.5-year gap between mammograms. Among women aged 30-59 years, 59.3% of commercially insured women and 31.4% of Medicaid-insured women received two or more Pap tests. The proportion of patients with a >3.5-year gap between Pap tests was 33.9% (commercially insured) and 57.1% (Medicaid-insured). Among women aged 50-59 years, 63.3% of commercially insured women and 47.2% of Medicaid-insured women were screened at least one time for colorectal cancer. Almost all women aged 30-59 years (commercially insured, 99.1%; Medicaid-insured, 98.9%) had at least one healthcare encounter. CONCLUSIONS: Breast and cervical cancer screenings remain underutilized among both commercially insured and Medicaid-insured populations, with lower rates among the Medicaid-insured population. However, almost all women had at least one healthcare encounter, suggesting opportunities for better coordinated care.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Neoplasias Colorretais / Aceitação pelo Paciente de Cuidados de Saúde / Neoplasias do Colo do Útero / Programas de Rastreamento Tipo de estudo: Diagnostic_studies / Guideline / Observational_studies / Prognostic_studies / Screening_studies Limite: Adult / Female / Humans / Middle aged País/Região como assunto: America do norte Idioma: En Revista: Am J Prev Med Assunto da revista: SAUDE PUBLICA Ano de publicação: 2019 Tipo de documento: Article País de publicação: Holanda

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Neoplasias Colorretais / Aceitação pelo Paciente de Cuidados de Saúde / Neoplasias do Colo do Útero / Programas de Rastreamento Tipo de estudo: Diagnostic_studies / Guideline / Observational_studies / Prognostic_studies / Screening_studies Limite: Adult / Female / Humans / Middle aged País/Região como assunto: America do norte Idioma: En Revista: Am J Prev Med Assunto da revista: SAUDE PUBLICA Ano de publicação: 2019 Tipo de documento: Article País de publicação: Holanda